PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20955720-7	2011	Similarly in the presence of amantadine or memantine the potency of Mg(2+) in blocking GluN1/GluN2A NMDARs was reduced.	Magnesium	68-70	glutamate ionotropic receptor NMDA type subunit 2A	Homo sapiens	93-99	
29644724-6	2018	In functional studies, the GluN2A-A643D mutation increased the potency of the agonists L-glutamate and glycine and decreased the potency of endogenous negative modulators, including protons, magnesium and zinc but reduced agonist-evoked peak current response in mammalian cells, suggesting that this mutation has a mixed effect on N-methyl-d-aspartate receptor function.	Magnesium	191-200	glutamate ionotropic receptor NMDA type subunit 2A	Homo sapiens	27-33	
23447622-9	2013	Mutating the GluN2 S/L site of GluN2A subunits from serine (found in GluN2A and GluN2B subunits) to leucine (found in GluN2C and GluN2D) greatly diminished both voltage-dependent gating and slow Mg(o)(2+) unblock.	Magnesium	195-197	glutamate ionotropic receptor NMDA type subunit 2A	Homo sapiens	31-37	
23447622-9	2013	Mutating the GluN2 S/L site of GluN2A subunits from serine (found in GluN2A and GluN2B subunits) to leucine (found in GluN2C and GluN2D) greatly diminished both voltage-dependent gating and slow Mg(o)(2+) unblock.	Magnesium	195-197	glutamate ionotropic receptor NMDA type subunit 2A	Homo sapiens	69-75